 |
|
|
|
       |
|
|
|
|
|
|
|
Help
us fund
Donations may be made to the
1332 N. Halsted St.
Chicago,
IL 60622 312-587-9272
|
Research on Pulmonary Fibrosis that has been funded by the Pulmonary Fibrosis Foundation. Research Program Grants in Pulmonary Fibrosis $8,000 to Duke University in Durham, North Carolina. Awarded to Dr. David Schwartz $8,000 to University of Michigan in Ann Arbor, Michigan. Awarded to Dr. Galen Towes $8,000 to University of California at Los Angeles. Awarded to Dr. Robert Strieter $50,000 to National
Jewish Medical & Research Center in Denver, Colorado. Awarded to $25,000 to University of Michigan, Ann Arbor, Michigan. Awarded to Dr. Eric White $35,000 to University of Pittsburgh, Pittsburgh, Pennsylvania. Awarded to Dr. Yingze Zhang. $50,000 to Baylor College of Medicine, Houston, Texas. Awarded to Dr. Pyong Woo Park. Co-funded with the American Lung Association. $15,000 to American
College of Chest Physicians, Northbrook, Illinois. Conference on the
$45,000
to University of Vermont, Burlington, Vermont. Awarded to Navdeep Singh,
MBBS
$20,000 to Duke University. Awarded to Dr. David Schwartz to study the genetics of Pulmonary Fibrosis. Co-funded with the William E. Simon Foundation.
$50,000 to Baylor College
of Medicine, Houston, Texas. Awarded to Dr. Pyong Woo Park. Co-funded with the American Lung
Association. Second year grant.
$50,000 to Brigham and Women's Hospital, Boston, Massachusetts,
Dr. Caroline A. Owen. Co-funded with the American Thoracic Society for
Research in Pulmonary Fibrosis. Second year grant.
$40,000 to Massachusetts General Hospital. Awarded to Dr. Andrew M. Tager to study the Regulation of Pulmonary Fibrosis by LPA and its Receptor LPA1. September 1, 2006
$10,000 to the American College of Chest Physicians for Pulmonary Fibrosis Research
$5,000 to the Willett Foundation which provides funding for needy patients who are undergoing Lung Transplants
$426,481.36 to establish a Pulmonary Fibrosis Foundation Research Center of Excellence at the University of Chicago. The research will cover two areas. First, to find an effective treatment for Pulmonary Fibrosis. Second, to study the high rejection and failure rate in Lung Transplants and find a solution to this problem. This is a four year grant starting in the Fall, 2006.
$5,000 to the University of Vermont to help support a conference on "Stem Cells and Cellular Therapies in Lung Biology and Lung Diseases. The other sponsors are: National Institutes of Health, American Thoracic Society, the University of Vermont College of Medicine, Alpha-1 Foundation and the Vermont Lung Center
$40,500 to Brigham and Women's Hospital. Awarded to Dr. Scott L. Schissel to study ACLP Regulation of Myofibroblast-mediated Collagen Matrix Remodeling in Pulmonary Fibrosis
$100,000 to University of Michigan. Awarded to Dr. Galen Toews to study the possibility that the Epstein-Barr virus leads to an increased production of lung fibrocytes which cause Pulmonary Fibrosis
Awards Pending
$50,000 Co-funding with the Rare Lung Disease Consortium for Clinical Training in Pulmonary Fibrosis Treatment.
$574,518.64 to the Pulmonary Fibrosis Foundation Research Center of Excellence at the University of Chicago. The research will cover two areas. First, to find an effective treatment for Pulmonary Fibrosis. Second, to study the high rejection and failure rate in Lung Transplants and find a solution to this problem. This is a three year grant starting in the Fall, 2006.
$100,000 to the University of Vermont. Awarded to Dr. Daniel Weiss to study the use of Stem Cells as a treatment for Pulmonary Fibrosis
Total grants funded or pending $1,810,500.00
Latest update April 03, 2008 |
